Login
$AXSM
$137.01 -$4.68 (3.3%) Live

$AXSM SEC Filings

Filed On Filing
02 Nov 2026 10-Q
02 Nov 2026 8-K: Results of Operations and Financial Condition; Other Events

Total 3Q 2026 net product revenue of $259.7 million, representing 52% year-over-year growth

03 Sep 2026 Form 4: Jacobson Mark L., Chief Operating Officer

Received 10,000 shares by exercise or conversion ($130K) · Sold 10,000 shares ($2.09M)

03 Sep 2026 144
10 Aug 2026 10-Q
10 Aug 2026 8-K: Results of Operations and Financial Condition; Other Events

Total 2Q 2026 net product revenue of $218.4 million, representing 46% year-over-year growth

07 Aug 2026 Form 4: Tabuteau Herriot, Director

Received 45,004 shares by exercise or conversion ($223K) · Sold 45,004 shares ($9.54M) · Received 4,660 shares by exercise or conversion ($23.1K) · 1 more

06 Aug 2026 144
05 Aug 2026 144
27 Jul 2026 SCHEDULE 13G/A
15 Jul 2026 8-K: Other Events

Axsome Therapeutics Announces FDA Acceptance of New Drug Application for AXS-12 for the Treatment of Cataplexy in Narcolepsy

01 Jul 2026 Form 4: Tabuteau Herriot, Director

Received 49,666 shares by exercise or conversion ($246K) · Sold 49,666 shares ($11.9M)

01 Jul 2026 144
11 Jun 2026 Form 4: Jeffs Roger, Director

Sold 286 shares ($70.4K) · Sold 286 shares ($71.2K)

11 Jun 2026 144
10 Jun 2026 Form 4: Jeffs Roger, Director

Received 1,429 shares by exercise or conversion

10 Jun 2026 Form 4: Saad Mark E, Director

Received 1,429 shares by exercise or conversion

10 Jun 2026 Form 4: Mahony Susan, Director

Received 1,429 shares by exercise or conversion · Sold 300 shares ($71.2K) · Sold 300 shares ($73.9K)

10 Jun 2026 Form 4: Coleman Mark, Director

Received 1,429 shares by exercise or conversion · Sold 643 shares ($160K)

10 Jun 2026 144

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support